Coronary artery disease in women;Koronare herzerkrankung bei frauen

Journal fur Kardiologie

Volumn 12, Issue 3-4, 2005, Pages 52-56

  Podczeck Schweighofer, Andrea ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMORBIDITY; CORONARY ARTERY DISEASE; HUMAN; MORTALITY; PROPHYLAXIS; REVIEW; RISK FACTOR;

EID: 17044432674     PISSN: 10240098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Khaw KT. Epidemiology of coronary heart disease in women. In: Julian DG, Wenger NK (eds). Women and heart disease. Dunitz. London, 1999; 7-20.
2. Fried LP, Becker DM. Smoking and cardiovascular disease. In: Douglas PS (ed). Cardiovascular health and disease in women. Saunders, Philadelphia, 1993; 217ff.
3. Bostom AG, Gagnon DR, Cupples A, Wilson PW, Jenner JL, Ordovas JM, Schaefer EJ, Castelli WP. A prospective investigation of elevated lipoprotein a detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 1994; 90: 1688.
4. Coleman MP, Key TJA, Wang EY, Hermon C, Fentiman IS, AlLen DS, Jarvis M, Pike MC, Sanders TA. A prospective study of obesity, lipids, apolipoproteins and ischemic heart disease in women. Atherosclerosis 1992; 92: 177-85.
5. Denke MA. Primary prevention of coronary heart disease in postmenopausal women. Am J Med 1999; 107 (2A): 48S.
6. Howard BV, Cowan LD, Haffner SM. Women, diabetes, lipoproteins, and the risk for coronary heart disease. In: Forte TM (ed). Hormonal, metabolic, and cellular influences on cardiovascular disease in women. Futura Publishing Company, Armonk/NY, 1997; 262ff.
7. Robinson S, Henderson AD, Gelding SV. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. J Clin Endocrinol 1996; 44: 277-84.
8. Hayes SN, Taler SJ. Hypertension in women: current understanding of gender differences. Mayo Clin Proc 1998; 73: 157ff.
9. Kushi LH, Fee RM, Folsorn AR, Mink PJ, Anderson KE, Sellers TA. Physical activity and mortality in postmenopausal women. J Am Med Assoc 1997; 277: 1287-92.
10. Manson JE, Hu FB, Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, Speizer FE, Hennekens CH. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Eng J Med 1999; 341: 650-8.
11. Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, Pasternak R, Pearson TA, Redberg RF, Smith SC J, Winston M, Zinberg. Guide to preventive cardiology for women. Circulation 1999; 99: 2480-4.
12. Ridker PM, Buring JE, Shij J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-3.
13. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 2000; 342: 836-43.
14. Hansen CL, Crabbe D, Rubin S. Lower diagnostic accuracy of tallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size. J Am Coll Cardiol 1996; 28: 1214-9.
15. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary arteries disease in women. Am J Cardiol 1999; 83: 660.
16. Alexander KP, Shaw LJ, Delong ER, Mark DB, Petterson ED. Value of exercise treadmill testing in women. J Am Coll Cardiol 1998; 32: 1657.
17. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A, McArthur D, Froelicher V. Exercise-induced ST depression in the diagnostics of coronary artery disease in women. Circulation 1989; 80: 87-98.
18. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalised for coronary artery disease. N Engl J Med 1991; 325: 221-5.
19. Redberg RF. Diagnostic testing for coronary artery disease in women and gender differences in referral for revascularization. Cardiol Clin 1998; 16: 67-77.
20. Weintraub WS, Kosinski AS, Wenger NK. Is there a bias against performing coronary revascularization in women? Am J Cardiol 1996; 78: 1154-60.
21. BARI-Studie. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI-) Investigators. N Engl J Med 1996; 335: 217-25.
22. Bell MR, Berger PB, Holmes DR Jr, Mullany CJ, Bailey KR, Gersh BJ. Referral for coronary artery revascularization procedures after diagnostic coronary angiography: evidence for gender bias? J Am Coll Cardiol 1995; 25: 1650-5.
23. Becker RC, Terrin M, Ross R, Knatterud GL, Desvigne-Nickens P, Gore JM, Braunwald E. Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI-II) Investigators. Ann Intern Med 1994; 120: 638-45.
24. Christakis G, Weisel R, Buth K, Fremes SE, Rao V, Panagiotopoulos KP, Ivanov J, Goldman BS, David TE. Is body size the cause for poor outcomes of coronary artery bypass operations in women? J Thorac Cardiovasc Surg 1995; 110: 1344-58.
25. Douglas JS Jr, King SB III, Jones EL, Craver JM, Bradford JM, Hatcher CR Jr. Reduced efficacy of coronary bypass surgery in women. Circulation 1981; 64: II11-6.
26. Gilligan DM, Quyyumi AA, Connon RO III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2541-51.
27. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen and progestin use and this risk of cardiovascular disease. N Engl J Med 1996; 335: 453-61.
28. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801.
29. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH, Speizer FE. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336: 1769-75.
30. Herringtcn DM, Seboussin KB, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000; 343: 522-9.
31. Stampfer MJ, Willett WC, Colditz GA. A prospective study of postmenopausal estrogen therapy, and coronary heart disease. N Engl J Med 1968; 313: 1044-9.
32. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health study. N Engl J Med 1991; 325: 756-62.